Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,928
Closed -$69.7K 117
2025
Q3
$69.7K Sell
12,928
-5,815
-31% -$31.5K 0.07% 98
2025
Q2
$102K Sell
18,743
-7,128
-28% -$28.3K 0.1% 102
2025
Q1
$71.7K Sell
25,871
-166
-0.6% -$578 0.08% 107
2024
Q4
$88.8K Sell
26,037
-1,282
-5% -$3.7K 0.07% 144
2024
Q3
$80.3K Buy
27,319
+7,979
+41% +$26.3K 0.06% 136
2024
Q2
$65.8K Sell
19,340
-2,778
-13% -$9.09K 0.05% 136
2024
Q1
$67K Buy
22,118
+847
+4% +$2.97K 0.05% 141
2023
Q4
$89.6K Sell
21,271
-487
-2% -$2.64K 0.06% 150
2023
Q3
$149K Buy
21,758
+10,266
+89% +$90.7K 0.11% 150
2023
Q2
$120K Sell
11,492
-859
-7% -$7.68K 0.08% 141
2023
Q1
$86.1K Sell
12,351
-131
-1% -$1.14K 0.06% 144
2022
Q4
$75K Sell
12,482
-116
-0.9% -$857 0.06% 139
2022
Q3
$99K Buy
12,598
+351
+3% +$4.09K 0.08% 136
2022
Q2
$167K Buy
+12,247
New +$203K 0.04% 148
2021
Q4
Sell
-5,170
Closed -$282K 125
2021
Q3
$282K Buy
5,170
+625
+14% +$37.7K 0.19% 123
2021
Q2
$334K Buy
+4,545
New +$454K 0.23% 122

Other funds holding CVAC

Green Alpha Advisors's CVAC Position: Q4 2025 in Review

Green Alpha Advisors sold out of CureVac (CVAC) in Q4 2025, closing a stake of 12,928 shares — an estimated $69.7K sold.

Green Alpha Advisors first reported a position in CVAC in Q2 2021 and held it in 16 quarters. The position peaked at $334K in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Green Alpha Advisors reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Green Alpha Advisors sold 12,928 CureVac shares in Q4 2025, an estimated $69.7K.
  • Green Alpha Advisors first reported a position in CureVac in Q2 2021 and held it in 16 quarters.
  • Green Alpha Advisors's CureVac position peaked at $334K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Green Alpha Advisors's 13F filing for Q4 2025, filed 7 Jan 2026.